🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Management of Endometrial Hyperplasia during the Perimenopausal and Postmenopausal Periods: Chinese Clinical Practice Guidelines (2025 Edition)
Abstract:1 Background and Purpose Endometrial hyperplasia is a pathological condition characterized by abnormal glandular structure (including changes in size and shape) and an imbalance between glandular and stromal proportions (>1:1), which is a non-physiological and invasive endometrial proliferative disease [1]. The World Health Organization (WHO) updated its pathological classification criteria in 2020, categorizing endometrial hyperplastic lesions into two types [2]: (1) Endometrial hyperplasia without atypia (EH).
Keywords:endometrial hyperplasiamenopause transitional periodpostmenopausal perioddiagnosis and treatmentclinical practice guideline
Publication Date:2025-05-02
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:7( 534-540 )
Chinese Journal of Practical Gynecology and Obstetrics

Chinese Journal of Practical Gynecology and Obstetrics

ISTICPKUCSCD
ISSN:1005-2216
Year, Vol.(Issue):2025,41(5)